Your browser doesn't support javascript.
loading
Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors.
Davis, S Lindsey; Ionkina, Anastasia A; Bagby, Stacey M; Orth, James D; Gittleman, Brian; Marcus, Joshua M; Lam, Elaine T; Corr, Bradley R; O'Bryant, Cindy L; Glode, Ashley E; Tan, Aik-Choon; Kim, Jihye; Tentler, John J; Capasso, Anna; Lopez, Kyrie L; Gustafson, Daniel L; Messersmith, Wells A; Leong, Stephen; Eckhardt, S Gail; Pitts, Todd M; Diamond, Jennifer R.
Afiliação
  • Davis SL; University of Colorado Cancer Center, Aurora, Colorado.
  • Ionkina AA; University of California, Irvine, Irvine, California.
  • Bagby SM; University of Colorado Cancer Center, Aurora, Colorado.
  • Orth JD; University of Colorado Boulder, Boulder, Colorado.
  • Gittleman B; University of Colorado Cancer Center, Aurora, Colorado.
  • Marcus JM; University of Alabama at Birmingham, Birmingham, Alabama.
  • Lam ET; University of Colorado Cancer Center, Aurora, Colorado.
  • Corr BR; University of Colorado Cancer Center, Aurora, Colorado.
  • O'Bryant CL; University of Colorado Cancer Center, Aurora, Colorado.
  • Glode AE; University of Colorado Cancer Center, Aurora, Colorado.
  • Tan AC; Moffitt Cancer Center, Tampa, Florida.
  • Kim J; University of Colorado Cancer Center, Aurora, Colorado.
  • Tentler JJ; University of Colorado Cancer Center, Aurora, Colorado.
  • Capasso A; Department of Oncology, The University of Texas at Austin, Dell Medical School, Austin, Texas.
  • Lopez KL; University of Colorado Cancer Center, Aurora, Colorado.
  • Gustafson DL; Colorado State University, Fort Collins, Colorado.
  • Messersmith WA; University of Colorado Cancer Center, Aurora, Colorado.
  • Leong S; University of Colorado Cancer Center, Aurora, Colorado.
  • Eckhardt SG; Department of Oncology, The University of Texas at Austin, Dell Medical School, Austin, Texas.
  • Pitts TM; University of Colorado Cancer Center, Aurora, Colorado.
  • Diamond JR; University of Colorado Cancer Center, Aurora, Colorado. Jennifer.Diamond@cuanschutz.edu.
Clin Cancer Res ; 26(17): 4633-4642, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32414750
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Azepinas / Benzoxazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores de Proteínas Quinases / Neoplasias Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Azepinas / Benzoxazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores de Proteínas Quinases / Neoplasias Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article